BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial

Chun Chin Chang; Norihiro Kogame; Taku Asano; Clemens von Birgelen; Manel Sabaté; Yoshinobu Onuma; Patrick W. Serruys

doi:10.4244/eij-d-19-00566

Related publications

Article2014

NOBORI™ biodegradable-polymer biolimus-eluting stent versus durable-polymer drug-eluting stents: A meta-analysis

Yao‐Jun Zhang, Fei Ye, Javaid Iqbal, Shengjie Dong, Christos V. Bourantas, Nai‐Liang Tian, Patrick W. Serruys, Shao-Liang Chen

International Journal of Cardiology

Article2008

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

Stephan Windecker, Patrick W. Serruys, Simon Wandel, Paweł Buszman, Stanisław Trznadel, Axel Linke, Karsten Lenk, Thomas Ischinger, Volker Klauß, Franz R. Eberli, Roberto Corti, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Simon Davies, Robert‐Jan van Geuns, Pedro Eerdmans, Gerrit-Anne van Es, Bernhard Meier, Peter Jüni

The Lancet

Article2020

Final 3-Year Outcomes of MiStent Biodegradable Polymer Crystalline Sirolimus-Eluting Stent Versus Xience Permanent Polymer Everolimus-Eluting Stent

Kuniaki Takahashi, Patrick W. Serruys, Norihiro Kogame, Paweł Buszman, Philipp Lurz, Gillian A.J. Jessurun, Karel T. Koch, Roland P.T. Troquay, Bas Hamer, Ton Oude Ophuis, Krzysztof Milewski, Sjoerd H. Hofma, Joanna J. Wykrzykowska, Yoshinobu Onuma, Robbert J. de Winter, William Wijns

Circulation Cardiovascular Interventions

Article2012

THE RESOLUTE ZOTAROLIMUS-ELUTING STENT IN PATIENTS WIH DIABETES MELLITUS: TWO YEAR OUTCOMES

Alan C. Yeung, Martin B. Leon, Sigmund Silber, Patrick W. Serruys, Stephan Windecker, Jorge Belardi, Ian T. Meredith, Franz ndash Josef Neumann, Petr Widimský, Shigeru Saito, Joseph M. Massaro, Laura Mauri

Journal of the American College of Cardiology

Article2011

The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)

Joanna J. Wykrzykowska, Patrick W. Serruys, Paweł Buszman, Axel Linke, Thomas Ischinger, Volker Klauß, Franz R. Eberli, Roberto Corti, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Robert‐Jan van Geuns, Gerrit-Anne van Es, Peter Jüni, Stephan Windecker

EuroIntervention